| Israel | Turki | Austria | |
| Operasi sarkoma | - | dari $10,000 | dari $35,000 |
| Pengobatan kompleks untuk sarkoma Ewing | dari $71,100 | dari $30,000 | dari $55,000 |
300+ transplantasi sumsum tulang dan darah tali pusat – Dr. Ronit El Hasid memimpin Departemen Onkohematologi dan Onkologi Anak di Rumah Sakit Anak Dana Dwek.
Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.
The primary goal of sarcoma surgery in Israel is radical resection to achieve negative margins and ensure no cancer cells remain. Surgeons prioritize limb-salvage techniques and bone reconstruction using 3D printing to maximize physical mobility and preserve long-term quality of life for the patient.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center leverage massive patient volumes of 1,900,000 annually to refine precision protocols. This high volume allows surgeons to specialize in rare subtypes like Ewing's sarcoma, often integrating innovative HIPEC or cellular therapies directly into the surgical oncology plan. Many patients choose Israel because top specialists often hold dual credentials from prestigious US and Israeli medical institutions.
Patient Consensus: Patients value the focus on functional recovery, noting that surgeons prioritize saving limbs even in complex cases. The practical reality often involves a highly coordinated team of oncologists and pathologists who review margins in real-time.
Sarcoma surgery in Israel focuses on limb-sparing techniques and precise tumor removal. Surgeons utilize wide local excision for soft tissue tumors and specialized bone resection for osteosarcomas. Advanced reconstructions often involve allografts or titanium prosthetics within Joint Commission International-accredited facilities to prioritize functional preservation.
Bookimed Expert Insight: While many countries focus on basic resection, Israeli centers like Sheba Medical Center integrate cellular therapy research into surgical plans. Surgeons here often collaborate with in-house biotherapy centers to combine tumor removal with advanced immunotherapies. This high-volume environment, performing over 45,000 annual operations, ensures surgeons maintain elite proficiency in rare reconstruction cases.
Patient Consensus: Patients emphasize discussing the choice between natural allografts and durable prosthetic implants with surgeons early. Most prioritize centers where orthopedic oncologists can perform limb-sparing procedures instead of amputation.
Sarcoma surgery in Israel often serves as the primary curative step, though additional treatment depends on the tumor subtype, stage, and molecular profile. Most patients require adjuvant therapies such as radiation, chemotherapy, or precision immunotherapy to eliminate microscopic disease and prevent recurrence.
Bookimed Expert Insight: While many countries follow standard protocols, Israel’s approach focuses heavily on genetic profiling. Dr. Iris Kventsel at Sheba Medical Center integrates targeted therapies with cellular treatments like HIPEC. This precision often reduces unnecessary radiation for specific subtypes identified through molecular testing.
Patient Consensus: Many find that multidisciplinary teams in Israel prioritize balancing tumor removal with preserving limb function. Patients emphasize the importance of verifying if adjuvant radiation is needed by seeking specialized second opinions.
A multidisciplinary team (MDT) in sarcoma care acts as a specialized tumor board where orthopedic surgeons, pathologists, medical oncologists, and radiologists collaborate to treat rare tumors. This collective expertise ensures accurate diagnostic pathology and coordinates complex sequences of surgery, radiation, and innovative systemic therapies.
Bookimed Expert Insight: Israeli centers like Sheba and Assuta utilize dedicated sarcoma MDTs rather than general boards. This matters because high-volume centers, such as Sheba which serves 2 million patients annually, frequently include molecular pathologists. These experts identify specific genetic markers crucial for accessing precision medicine and clinical trials that are often unavailable in general hospitals.
Patient Consensus: Patients emphasize that having an orthopedic oncologist lead the team is vital for limb preservation and survival. Many recommend an initial visit to Israel to personally consult with the MDT and align all medical files before starting treatment.
Israel is a global leader in advanced sarcoma surgery, offering sophisticated limb-sparing techniques, 3D-printed bone reconstructions, and navigation-assisted tumor resections. Specialized centers like Sheba and Sourasky prioritize functional preservation by integrating intraarterial chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) to shrink complex tumors before precise surgical removal.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center are unique because they manufacture advanced cellular treatments in-house. While many global clinics only offer standard surgery, Sheba integrates proprietary CAR-T and TIL therapies within their biotherapy center. This allows surgeons to treat high-risk, metastatic sarcoma cases that might be considered inoperable elsewhere.
Patient Consensus: Seeking a dedicated orthopedic oncologist is essential, as patients report that specialized limb-sparing techniques are often viable even when amputation was previously suggested. Successful outcomes frequently depend on a multimodal approach where surgery is strictly coordinated with precise preoperative radiation.
Most patients secure an initial sarcoma consultation in Israel within 24 to 48 hours for urgent cases. Surgery typically follows within 7 to 21 days after diagnosis completion. Joint Commission International-accredited centers like Sheba and Assuta prioritize these aggressive tumors to ensure rapid multidisciplinary care.
Bookimed Expert Insight: While initial consultations happen fast, diagnostic speed is the real bottleneck. Assuta Medical Center's ability to bundle PET-CT and biopsies into a 3-day window is a major advantage. This speed is critical for aggressive types like Ewing's sarcoma where time is the most valuable factor.
Patient Consensus: Patients emphasize that having referrals marked as urgent is vital for speed. Many recommend calling hospital coordinators daily to claim cancellations, which often moves surgery dates up by weeks.
Patients can access specialized second opinion consultations for sarcoma surgery in Israel through in-person visits or remote video conferencing. Leading JCI-accredited centers like Sheba Medical Center and Tel Aviv Sourasky Medical Center provide expert reviews of complex bone and soft tissue cases.
Bookimed Expert Insight: While many seek a second opinion for surgical techniques, the real value in Israel lies in the mandatory pathology re-evaluation. Centers like Sheba and Assuta Medical Center prioritize re-reading original biopsy slides because sarcoma misclassification is common. Getting a molecular diagnosis from these high-volume labs often changes the recommended chemotherapy protocol before surgery even begins.
Patient Consensus: Accuracy is the primary concern, and patients emphasize that having physical biopsy slides and digital imaging discs ready is essential for a fast, independent report. Many appreciate the direct coordination through dedicated international departments which helps manage the logistical complexity of remote reviews.